Introduction
The p53 tumor suppressor protein is mutated frequently in human cancer, with the most common alterations being point mutations which inactivate its DNA binding domain (reviewed in Donehower and Bradley, 1993; Levine, 1993) . Mutant alleles from tumor cells usually exhibit dominant inhibitory activity, because the mutant protein can oligomerize with normal p53 and abolish the DNA binding activity of the oligomer. In this manner, point mutations in one allele eliminate p53 function in the cell. The frequency with which such mutations accumulate in cancer indicates that p53 has a crucial role in preventing inappropriate cell division.
A large body of evidence indicates that p53 is a transcription factor which participates in cell cycle checkpoint processes (reviewed in Gottlieb and Oren, 1996; Ko and Prives, 1996) . Clues to its function were suggested initially by observations that DNA damage induces p53 and that cells lacking p53 are genetically unstable (Livingstone et al., 1992; Harvey et al., 1993; DiLeonardo et al., 1994) . As part of a checkpoint to monitor genomic integrity, cell cycle inhibition by p53 could allow DNA repair processes to act, thereby helping to prevent the propagation of damaged DNA (Lane, 1992) . p53 also participates in other types of checkpoints, for example, one which monitors the state of nucleotide pools in proliferating cells (Linke et al., 1996) . A major pathway for cell cycle inhibition in the G1 phase is based on p53-mediated transcriptional activation of p21WAF1 (el-Deiry et al., 1994; Brugarolas et al., 1995; Deng et al., 1995) , a cell cycle-dependent kinase inhibitor (Harper et al., 1993; Xiong et al., 1993) . In this pathway, p21WAF1 induction leads to inhibition of the cell cycle kinase cdk4/6 and subsequent accumulation of the unphosphorylated form of the retinoblastoma protein (Rb), which arrests cells in the G1 phase of the cell cycle. Other pathways that allow p53 to inhibit the cell cycle operate in the G2 phase and in mitosis (Agarwal et al., 1995; Cross et al., 1995; Guillouf et al., 1995; Stewart et al., 1995) , but the mechanisms are unknown.
Under some circumstances, p53 can also induce programmed cell death, or apoptosis (reviewed in Bates and Vousden, 1996; Gottlieb and Oren, 1996; Ko and Prives, 1996; White, 1996) . The existence of certain tumor-derived mutations which eliminate the capacity to induce cell death but not cell cycle arrest has led to the suggestion that the former function is more important for preventing malignancy (Friedlander et al., 1996; Ludwig et al., 1996; Rowan et al., 1996) . Gene activation by p53 appears to be necessary for inducing apoptosis in many cells (Sabbatini et al., 1995b; Attardi et al., 1996; Yonish-Rouach et al., 1996) . Analysis of relevant target genes have argued against a role for p21WAF1 (Attardi et al., 1996) but supported roles for BAX Selvakumaran et al., 1994; Miyashita and Reed, 1995; Han et al., 1996) , which in¯uences cell death susceptibility through interactions with BCL-2 family members (White, 1996) , and IGF-BP3 (Buckbinder et al., 1995) , which sequesters the cell survival factor insulin-like growth factor-1 (Baserga, 1994) . p53-mediated apoptosis clearly involves more than downstream gene activation, however, because it is apparent that the cellular response to p53 is also aected by p53 levels and extent of DNA damage (Chen et al., 1996) , growth factor conditions (Canman et al., 1995) , Rb status (Morgenbesser et al., 1994; Canman et al., 1995; Hansen et al., 1995) , and other aspects of the cell's genetic background (Polyak et al., 1996) . The ability of p53 to repress transcription (Mack et al., 1993) may also be important (Sabbatini et al., 1995a) . Finally, under certain circumstances, gene regulation may be completely dispensable (Caelles et al., 1994; Haupt et al., 1995) . Thus, exactly how the cell makes the arrest/ death decision in response to p53 and death inducing genes which are p53-dependent is unclear and may be quite complex.
One approach to this issue is to de®ne regions of p53 that participate selectively in apoptosis. We analysed a possible role for the polyproline (PP) region which is located between the DNA binding and transactivation domains, a region which contains PXXP motifs characteristic of SH3 domain interaction sites and which is necessary for ecient growth suppression (Walker and Levine, 1996) . While not generally altered in tumor cells, the PP region is the site of a familial mutation in a breast cancer pedigree (Sun et al., 1996) , consistent with the assertion that it is functionally important. Our analysis demonstrates that the PP region is crucial for p53-mediated apoptosis but largely dispensable for transactivation, cell growth arrest, or suppression of cell transformation.
Results
The PP region is dispensable for DNA binding and cell growth inhibition
The location and conserved sequences of the PP region in p53 is shown in Figure 1 . A deletion mutant lacking the minimal conserved region between the murine and human proteins, termed p53DPP, was constructed by deleting aa 77 ± 89 from murine p53, a segment which includes two copies of the SH3 binding motif PXXP (Koyama et al., 1993) which has been noted in this region (Walker and Levine, 1996) . Expression of p53DPP was con®rmed by immunoprecipitation from in vitro translation reactions and from transiently transfected COS cells metabolically labeled with 35 Smethionine (see Figure 2a) . Consistent with the size of the expected product, a *50 kD polypeptide slightly smaller than wt p53 was observed by SDS ± PAGE, following precipitation with a murine-speci®c anti-p53 antibody.
Since PP region is not located within the oligomerization, DNA binding, or transactivation domains, its deletion was not anticipated to aect p53's ability to speci®cally recognize DNA or inhibit cell growth. The ®rst prediction was con®rmed by comparing the DNA binding activity of in vitro translated p53DPP and p53 in an electrophoretic mobility shift assay, using a 32 P-labeled oligonucleotide that contained an optimized p53 recognition sequence . The binding activity of p53DPP was similar to wt p53, except that a slightly reduced mobility shift of the bound oligonucleotide was seen, consistent with its relatively smaller molecular weight (see Figure 2b) . Two standard assays were employed to examine the prediction that p53DPP would retain growth inhibitory activity. In the ®rst, p53 null SAOS-2 osteosarcoma cells were transfected with neomycin resistance gene (neo r )-marked expression vectors containing wt p53, p53DPP, or no insert, and inhibition of G418-resistant colony formation was compared. In the second, primary rat embryo ®broblasts (REFs) or baby rat kidney epithelial cells (BRK cells) were cotransformed by adenovirus E1A and oncogenic RAS plus either wt p53, p53DPP, or no insert vectors, and suppression of focus formation was monitored. We observed that wt p53 and p53DPP suppressed G418-resistant colony formation in SAOS-2 cells and foci formation in both REFs and BRK cells with similar eciency (see Figure 2c and d). We concluded that the PP region was dispensable for DNA binding, inhibition of cell growth, and suppression of cell transformation.
The PP region is necessary to induce apoptosis
To assay p53-mediated cell cycle arrest and apoptosis, we employed a well-characterized cell system using BRK cells transformed by the concerted action of Figure 1 PP region deletion mutant. The ®gure depicts the location of the PP region in murine p53 (aa 77 ± 89) relative to the transactivation and DNA binding domains of murine p53 Wang et al., 1993; Ko and Prives, 1996; Walker and Levine, 1996) . The position of the valine 135 temperature-sensitive mutation (Michalovitz et al., 1990) included in some constructs in this report is also noted. Amino acid residues conserved in murine and human p53 are aligned below. Residues 77 ± 89 in murine p53 include two copies of the putative SH3 binding motif PXXP, both of which were deleted from either wild-type or temperature-sensitive forms of murine p53 b Figure 2 The PP region is dispensible for DNA binding, inhibition of SAOS-2 cell growth, and suppression of cell transformation.
(a) Expression. wt p53 or p53DPP was expressed by in vitro translation or by COS cell transfection, followed by immunoprecipitation with anti-p53 antibody pAb248. (b) DNA binding. Complexes formed between a 32P-labeled oligonucleotide containing a wt p53 binding site and in vitro translation extracts programmed with vector, wt p53, or p53DPP were examined by an electrophoretic mobility shift assay as described . (c) Inhibition of cell growth and cell transformation. SAOS-2 cells were transfected with equivalent amounts of neomycin-resistance (neo r )-tagged vector containing no insert, wt p53, p53DPP, and G418-resistant colonies were methanol ®xed and stained with Coomassie blue 3 weeks later. REFs were transfected with adenovirus E1A and oncogenic RAS expression plasmids plus the same vectors as above and foci were scored 16 days later. , a temperature-sensitive (ts) dominant inhibitory mutant (Michalovitz et al., 1990) . Both E1A expression and inhibition of endogenous p53 are required to transform primary BRK cells (Debbas and White, 1993) . p53 V135 assumes a mutant con®guration at the nonpermissive temperature of 388C, such that it retains the ability to oligomerize but not to bind DNA (Michalovitz et al., 1990) . Because heterooligomeric forms of p53 containing the mutant lack DNA binding activity, overexpression of p53 V135 in BRK cells at 388C dominantly inhibits the function of the endogenous wt p53 protein. At 328C, the permissive temperature for wild-type function, p53 V135 assumes a native con®guration which is compatible with DNA binding and normal p53 function (Michalovitz et al., 1990) . Within 24 h of activation of wt p53, following temperature shift from 388C to 328C, BRK E1A/p53ts cells undergo both cell cycle arrest and apoptosis (Debbas and White, 1993; Sabbatini et al., 1995a; Han et al., 1996) . These events are linked to transcriptional activation of the p53 target genes p21WAF1, an inhibitor of the cyclindependent kinase cdk4/6 responsible for Rb phosphorylation, and BAX, a member of the BCL-2 family of apoptosis regulators that potentiates cell death (Debbas and White, 1993) .
We analysed the eect of the PP region in this system by shuttling the deletion in p53DPP into the p53 V135 (p53ts) dominant inhibitory mutant, generating a double mutant termed p53tsDPP. Since p53DPP could speci®cally bind DNA, it could clearly oligomerize. Therefore it was expected that the p53tsDPP double mutant would retain its dominant inhibitory activity at 388C, since this depends upon oligomerization potential. Consistent with this expectation, p53tsDPP cooperated with oncogenic RAS in transformation of REFs and cooperated with E1A to transform primary BRK cells (data not shown). We concluded that the PP deletion did not aect the oncogenic potential of the p53ts dominant inhibitory mutant.
Transformed BRK foci generated by cotransfection with E1A and p53tsDPP were cloned and expanded into cell lines to study cell phenotypes at the permissive and nonpermissive temperatures for p53 function. Two representative cell lines, termed DPP1 and DPP2, were extensively analysed and described below. The BRK E1A/p53ts control cell line used in these experiments, An1, was generated by transformation with E1A and the parental p53ts and has been characterized previously (Debbas and White, 1993) . Expression of E1A and the mutant p53 polypeptides was con®rmed in each line by Western analysis (see Figure 3 ). E1A was expressed at slightly higher levels in DPP1 and DPP2 relative to An1. Mutant p53 expression was detected in each cell line, with smaller polypeptides accumulating to slightly lower levels in DPP1 and DPP2 cells relative to An1. Consistent with their identification as p53ts and p53DPPts, the sizes of the mutant p53 polypeptides observed were consistent with previous observations in An1 cells (Debbas and White, 1993) and in COS cells (see Figure 2a) . The endogenous rat p53 polypeptide, which comigrated with p53ts in An1 cells, could be observed above the smaller murine p53tsDPP polypeptide in DPP1 and DPP2 cells (indicated by a dot on the right side of the blot in Figure 3 ).
The eects of p53DPP on the morphology, cell growth, apoptotic index, and cell cycle phase distribution were examined by comparing DPP1 and DPP2 cell populations to control cell populations incubated at 388C or 328C. Morphology was examined by phase microscopy (see Figure 4a ). Within 3 days of temperature shift, a dramatic dierence in the response of p53ts-and p53tsDPP-expressing cells was evident. As observed previously (Debbas and White, 1993) , An1 exhibited massive cell death at 328C, due to the presence of wt p53. In sharp contrast, DPP1 and DPP2 showed little sign of cell death. A slight increase in the size of DPP1 and DPP2 cells was observed at 328C, a feature previously associated with p53-mediated arrest in BRK cells (Debbas and White, 1993) . Growth curve experiments indicated that DPP1 and DPP2 cell populations incubated at 328C underwent growth arrest without loss of viability. This was not a nonspeci®c eect of low temperature, because a temperature-insensitive BRK control cell line (DD1) generated by transformation with E1A and a p53 dominant inhibitory mutant comprising only the Cterminal oligomerization domain (Shaulian et al., 1992) was still able to proliferate at 328C (see Figure 4b ). To con®rm that the loss of viability observed in An1 cell populations at 328C was due to apoptosis, chromatin integrity was monitored by staining with the fluorescent DNA dye Hoescht 33342 followed by fluorescence microscopy (see Figure 4c ). As anticipated, shifting An1 cultures to 328C caused a signi®cant increase in the proportion of cells exhibiting condensed chromatin characteristic of apoptosis. In contrast, no increase in cells containing condensed chromatin was seen in DPP1 and DPP2 cultures incubated at 328C. We concluded that p53DPP retained the ability to activate growth arrest but lacked the ability to induce apoptosis.
One explanation for these data was that there was a interaction between the V135 and DPP mutations in the doubly mutated p53tsDPP polypeptide, such that apoptotic signaling was nonselectively hindered. To rule out this possibility, we tested the ability of p53DPP (which has the PP deletion in a wt p53 backbone) to kill LoVo, a colon carcinoma cell line which undergoes apoptosis in response to wt p53 Selective role of p53 PP region in apoptosis D Sakamuro et al overexpression (Polyak et al., 1996) . A transient cotransfection experiment was performed in which a green¯uorescent protein (GFP) expression vector (GibcoBRL) was introduced at a 1 : 5 ratio with vectors containing no insert, wt p53, or p53DPP. One day after transfection, viable LoVo cells were brie¯y stained with Hoescht 33342 and transfected cells were identi®ed by¯uorescence microscopy using the FITC ®lter. Green¯uorescing cells were counted and the proportion that were apoptotic were scored by examination for both round morphology, using the FITC ®lter, and for the appearance of condensed chromatin, using the u.v. ®lter. The results of this experiment, shown in Figure 5 , indicated that p53DPP could not kill LoVo cells. This ®nding argued against interaction of the DPP and V135 mutations and supported the conclusion that PP region was critical for inducing apoptosis.
The PP region is not involved in cell cycle control
Since the PP region was dispensable for cell growth inhibition, but required for apoptosis, it seemed likely that the ability of p53DPP to arrest growth was based on cell cycle inhibition. If so, p53DPP would be predicted to resemble p53 in its ability to inhibit cell cycle transit. To test this,¯uorescence-activated cell sorting (FACS) experiments were performed with the BRK cell lines to assess their cell cycle distribution at 388C and 328C. An1, DPP1, and DPP2 cells were incubated at 388C or shifted to 328C for 3 days, ®xed in ice-cold ethanol, stained with the DNA binding dye propidium iodide, and analysed by¯ow cytometry (Sakamuro et al., 1995) . As controls, we included An1/ BCL-X L , a derivative of An1 which ectopically expresses the apoptosis suppressor BCL-X L and which undergoes growth arrest but not apoptosis in response to wt p53 activation (GCP, unpublished results), and An1/neo, a matched vector-only control. The results of this experiment is shown in Figure 6 and Table 1 . All cell lines displayed typical patterns of cell cycle distribution at 388C. After 3 days incubation at 328C, the An1 and An1/neo populations were dominated by cells with a sub-G1 DNA content, consistent with apoptosis. In contrast, DPP1 and DPP2 populations showed no increase in sub-G1 cells but instead displayed signs of cell cycle inhibition in which cells accumulated in G1 phase. The DPP1 population incubated at 328C exhibited a 67% decrease in cells in S and G2/M and a 30% increase in cells in G1.
Similarly, the DPP2 population exhibited a 22% decrease in cells in S and G2/M and a 35% increase in cells in G1. The pattern of cell cycle distribution in An1/BCL-X L resembled that observed previously in An1 cells ectopically expressing BCL-2 (Chiou et al., 1994) , in which cells are arrested in multiple phases of the cell cycle. Thus, while PP deletion compromised apoptosis it was not mechanistically the same as that elicited by BCL-X L overexpression. We concluded that while the PP region was necessary for apoptosis it was dispensable for p53-mediated cell cycle arrest.
The PP region is largely dispensable for transactivation
In murine p53, the PP region is located at aa 77 ± 89, downstream of the transactivation domain loosely Figure 5 p53DPP lacks apoptotic potential in LoVo carcinoma cells. LoVo carcinoma cells were transfected with a green uorescent protein (GFP) vector plus vectors containing no insert, wt p53, or p53DPP, and stained with Hoescht 33342 to visualize nuclear chromatin. The proportion of green positive cells by immuno¯uorescence microscopy using the FITC ®lter which also displayed signs of chromatin condensation using the u.v. ®lter were scored. The average of two trials is shown Figure 6 The PP region is dispensible for cell cycle arrest by p53. Cells seeded overnight at 388C were incubated at the same temperature or shifted to 328C. After 3 days, cells were harvested and processed for¯ow cytometry as described (Sakamuro et al., 1995) Cells were cultured at the nonpermissive (388C) or permissive (328C) temperature for p53 function for 3 days, stained with the DNAbinding dye propidium iodide, and processed for¯ow cytometry as described in the Materials and methods. The percentage of the cell population with DNA contents indicative of various phases of the cell cycle are shown. Apoptotic cells display a sub-G1 DNA content by¯ow cytometry, due to DNA degradation Ko and Prives, 1996) . Because of its location, it might not be expected to play a central role in transactivation. However, since transactivation has been shown previously to be necessary for p53 to induce apoptosis in An1 cells (Sabbatini et al., 1995b) , and we have found the PP region to be crucial for apoptosis, we were interested in knowing whether it might contribute to the transactivation potential of p53.
To begin to address this issue, the level of expression of the p53 target genes p21WAF1 and BAX was determined by Western analysis in An1, DPP1, and DPP2 cells incubated at 388C or shifted to 328C for 1 ± 3 days. In each line, levels of p21WAF1 and 21 kD and 24 kD species of BAX were increased after temperature shift (see Figure 7) . This observation implied that PP deletion did not grossly aect transactivation potential. Some dierences in BAX expression were noted, for example, the 24 kD species of BAX was detectable in uninduced DPP1 cells but not An1 cells. However, at the simplest level of interpretation, it appeared that p53DPP retained the ability to activate transcription of both BAX and p21WAF1.
To further analyse a possible role for the PP region in transactivation, a series of transient transcription assays were performed. These assays employed luciferase reporter constructs containing an arti®cial promoter with multimerized p53 binding sites (pG13-luc) or a similar promoter with mutated binding sites (pMG13-luc) (el-Deiry et al., 1993). In the ®rst set of experiments, SAOS-2 cells were cotransfected with a bgal normalization plasmid, one of the reporters, and expression vectors containing no insert, p53ts, or p53tsDPP. After transfection, cells were maintained at 388C or shifted to 328C and then harvested and processed for analysis 48 h later. We observed that p53ts and p53tsDPP each lacked activity relative to empty vector at 388C, but at 328C transactivated the arti®cial promoter *329-fold and *100-fold, respectively (see Figure 8) . The activity depended upon speci®c DNA binding by p53, because both constructs lacked activity at 328C and 388C when assayed using the reporter containing mutated binding sites (data not shown). Trials using a reporter containing the p21WAF1 promoter (el-Deiry et al., 1993) showed no activation by either p53ts or p53tsDPP at 388C, but *4-fold activation by p53tsDPP compared to *5-fold activation by p53ts at 328C. Similar data with these reporters were obtained in assays performed using nontemperature sensitive wt p53 or p53DPP constructs at 388C. In a second type of experiment, An1, DPP1 or DPP2 cells were transfected with reporters only and cells were then maintained at 388C or shifted to 328C to activate the endogenous p53ts or p53ts8PP before luciferase/bgal assay 48 h later. As before, PP deletion aected activation potential only a few fold on either the arti®cial or p21WAF1 reporters (data not shown). We concluded that the transactivation potential of p53 was largely unaected by PP deletion.
Discussion
The ability of p53 to induce apoptosis may be important for its anti-tumor action but the underlying mechanisms have remained obscure. We found that the polyproline region (PP) located between the Eects of p53DPP on p21WAF1 and BAX induction in BRK cells. An1, DPP1, and DPP2 cells were incubated at 388C or for various times at 328C. Cell extracts were analysed by Western blotting, as described in the Materials and methods, using antip21 and anti-BAX antibodies Figure 8 Little role for the PP region in transactivation. SAOS-2 osteosarcoma cells were transiently transfected as described in the Materials and methods with vector, p53ts, or p53tsDPP, plus pG13-luc or pMG13-luc, luciferase reporters containing multimerized optimized or mutated DNA binding sites for p53 (elDeiry et al., 1993) . Immediately after transfection, cells were incubated at 388C or 328C for 48 h, at which time cell extracts were prepared and assayed for normalized luciferase activity 
The PP region and cancer
A familial mutation in a breast cancer family has recently been identi®ed within the PP region at a conserved proline at residue 82 which is encoded by exon 4 (Sun et al., 1996) . By de®ning a function for the PP region in apoptosis, one can suggest an explanation for the increased tumor susceptibility in this family: mutations in the PP region might allow cells containing damaged DNA to persist beyond the point at which they would normally be killed. If the loss of p53's apoptotic capability is a critical step in tumorigenesis, as has been hypothesized , then familial and sporadic mutations in the PP region would be anticipated with some frequency. However, since we found that PP deletion had limited eects on the ability to inhibit cell transformation or suppress tumor cell growth, mutations in the PP region might not be as frequent as those in the DNA binding domain, which have more pleiotropic eects. Further examination of exon 4 for mutations should shed light on this issue.
Apoptotic capacity is not required to inhibit tumor cell growth or cell transformation
We demonstrated that p53DPP was incapable of mediating E1A-induced apoptosis in BRK cells. Recent evidence had suggested that there may be a correlation between p53-mediated apoptosis and tumor suppression activity (Rowan et al., 1996) . However, we found that PP was not necessary to inhibit either SAOS-2 growth or cell transformation. These ®ndings sever the correlation between these activities, since they argue that there is not an obligate link between the ability to induce apoptosis and the ability to suppress transformed cell growth. In human p53, the PP region is larger and its deletion has been reported to reduce the eciency of growth suppression in H1299 non-small cell lung carcinoma cells *twofold (Walker and Levine, 1996) . Thus, while essentially dispensable, in certain contexts the PP region may augment the p53's growth inhibitory activity by contributing an apoptotic function(s). There is signi®cant evidence that apoptosis and G1 arrest by p53 are separated by its eects on p21WAF1, which is a major mediator of G1 arrest but not cell death (Brugarolas et al., 1995; Deng et al., 1995; Kobayashi et al., 1995; Waldman et al., 1995; Attardi et al., 1996) . Consistent with this separation, certain p53 mutants have been characterized which can arrest SAOS-2 growth but neither suppress cell transformation nor induce cell death (Crook et al., 1994; Rowan et al., 1996) . Connections between apoptosis and G2/M arrest functions (Agarwal et al., 1995; Cross et al., 1995; Guillouf et al., 1995; Stewart et al., 1995) have not been reported yet, but based on our results might be separable as well. Separation of p53's apoptotic and growth arrest functions is supported by studies of the eects of survival cytokines and BCL-2 on p53 function. IL3, erythropoietin, and c-KIT ligand block p53-mediated apoptosis but not growth arrest in murine erythroleukemia cells (Lin and Benchimol, 1995) . BCL-2 suppresses apoptosis by p53 but not inhibition of cell cycle transit in multiple phases of the cell cycle (Chiou et al., 1994) . Also, cotransfection of the BCL-2 family member BCL-X L can not relieve the suppression of E1A+RAS transformation by p53 (GCP, unpublished results). PP deletion, BCL-2 family members, and survival cytokine signals may mimic each other insofar as they can separate p53's growth arrest and apoptosis activities. In any case, our results support the interpretation that the apoptotic capacity of p53 is not necessary, although it may be sucient, to suppress tumor cell growth and cell transformation.
Role of the PP region in gene regulation
Previous studies performed in E1A/p53ts-transformed BRK cells and in p53 null normal ®broblasts has indicated that transactivation is necessary for apoptosis (Sabbatini et al., 1995b; Attardi et al., 1996) . Our ®ndings are compatible with these results but suggest connections to transactivation-independent apoptotic processes (Haupt et al., 1995) . In several assays, PP deletion caused few-fold reductions in transactivation activity relative to wild-type p53. Consistent with these results, similar reductions in transactivation activity occur following deletion of aa 68-117 (including PP) from murine p53-GAL4 chimeras (Hulboy and Lozano, 1994) . Deletion of the larger PP region encoded by human p53 (aa 62 ± 91) causes a slight increase in activity (Walker and Levine, 1996) . Taken together, a reasonable interpretation of these data is that the PP region has a limited role, if any, in transactivation. However, one can not rule out at this time the possibility of a selective role in activation of some but not all target genes.
We observed that p53DPP could not induce apoptosis in BRK cells even though it could induce p21WAF and BAX. Induction of p21WAF1 was unsurprising since p53DPP inhibited both cell growth and cell cycle transit, and p21WAF1 can mediate these eects (Waldman et al., 1995) . In contrast, from the simplest viewpoint, the induction of BAX would be unexpected. BAX has been linked to p53-mediated death in BRK cells (Han et al., 1996) but p53DPP could induce BAX even though it could not induce apoptosis. Taken together, one would conclude that BAX requires an accessory signal to eciently induce cell death. At least three mechanistic interpretations of the results are possible. First, the PP region may be needed to suppress a survival factor which can defeat BAX action. Second, the PP region may be required to activate a necessary death cofactor. Each of these interpretations rest upon a role for the PP region in regulating p53 target genes other than BAX. Finally, the PP region might be part of a transactivationindependent mechanism which cooperates with BAX to induce death. Although speculative, this interpretation would be supported by reports that p53 can elicit apoptosis by transactivation-independent mechanisms (Caelles et al., 1994; Haupt et al., 1995) . Whatever its nature, the requirement for a cooperative death signal appears to be surmountable, because overexpression of BAX is sucient to kill DPP cells (PS and EW, unpublished observations). Nevertheless, our results would indicate that a second event in addition to BAX transactivation is necessary for p53-mediated apoptosis.
Does the PP region constitute a binding site for nuclear SH3 proteins?
The mutation at codon 82 of human p53 in the breast cancer family causes a proline-to-leucine alteration (Sun et al., 1996) , destroying one of the putative SH3 binding PXXP motifs noted in the PP region (Walker and Levine, 1996) . However, whether the PP region physiologically interacts with SH3 proteins or participates in signal transduction is not yet clear. p53 associates with one protein, p53BP2 (Iwabuchi et al., 1994) , which although cytoplasmic harbors an SH3 domain necessary for interaction (Naumovski and Cleary, 1996) . However, a crystallographic determination of the p53-p53BP2 structure has indicated that the SH3 domain contacts not the PP region but a noncanonical target comprised of two loop regions within the p53 DNA binding domain (Gorina and Pavletich, 1996) . There are three known nuclear SH3 proteins that would be candidates for PP interaction, including c-ABL (Pendergast, 1996) and RAK (Cance et al., 1994; Craven et al., 1995) , two growth inhibitory tyrosine kinases, and BIN1, a MYC-interacting protein with features of a tumor suppressor (Sakamuro et al., 1996) . c-ABL has been reported to interact with and require p53 for its growth inhibitory action (Goga et al., 1995) , but neither links to apoptosis nor a role for the c-ABL SH3 region have been explored. The SH3 domain of BIN1 can interact with p53 in vitro but the physiological signi®cance of this interaction is not yet clear (DS and GCP, unpublished observations) .
The PP region could conceivably interact with adaptors which in¯uence transcription, specialized proteins that participate directly in signaling pathways controlling cell death, or both. Combinatorial models incorporating features of each aspect are possible, since p53 is a tetramer in cells . A transactivation-independent signaling role, while speculative, would be consistent with evidence that new protein synthesis is dispensable for p53-mediated death in some cells (Wagner et al., 1994) . Furthermore, it may provide a basis to explain how a non-DNA binding form of p53 encoding aa 1 ± 214 can induce apoptosis of HeLa cells (Haupt et al., 1995) , perhaps by titrating SH3 proteins that suppress death. Finally, PP-interacting proteins would be candidates for the dominant trans-acting death factors implicated in the dierential response of colon carcinoma cells to p53 (Polyak et al., 1996) . Identi®cation of proteins which interact physiologically with the PP region would be helpful to assess its function, because the structure of the interacting proteins could hint at roles in signal transduction, transcription, or both. Future work on its function should clearly move in this direction.
Materials and methods

Plasmids
A wild type murine p53 expression vectors, termed CMVp53, was constructed as follows. A 1.4 kb fragment containing the entire wt p53 coding region was excised from pGEMp53wtD with EcoRI and SalI and subcloned into pGEX(5X-1) (Pharmacia), and then shuttled as a BamHI ± NotI fragment into pcDNA3 (Invitrogen). pCMVp53ts is an expression vector of temperature-sensitive p53 V135 , which assumes a dominant inhibitory conformation at 38.58C but shifts to a wild type conformation and function at 328C (Michalovitz et al., 1987) . The ts-mutant allele of p53 V135 was generated by PCR using following primers and subcloned into pcDNA3:5' -TCT GGA TCC ACT GGA TGA CTG CCA TGG AGG AGT CAC AGT-3' (sense), 5' -GAT GAA TTC GTC GAC TCA GTC TGA GTC AGG CCC CAC TTT -3'(antisense), 5'-GCC AGC TGG TGA AGA CGT GCC CTG TGC-3'(ts-sense; the underlined nucleotide shows the position of the point mutation), and 5'-GCA CAG GGC ACG TCT TCA CCA GCT GGC-3'(ts-antisense). CMV-p53DPP and CMVp53tsDPP were also constructed by PCR using CMVp53 and CMVp53ts as a template DNA, respectively. Besides the sense and antisense primers described above, the other primer sets to introduce PP deletion (aa residues 77 ± 89) were as follows; 5'-TAA TCT AGA GGT CTC GGT GAC AGG GTC CTG TGC-3' and 5'-GGA TCT AGA CTG TCA TCT TTT GTC CCT TCT CAA-3'. These deletion constructs included the nonspeci®c residues SR at the fusion junction due to the restriction site added.
Cell culture
Primary rat embryo ®broblasts (REFs) were purchased from Whittaker and handled as described previously (Prendergast et al., 1992) . SAOS-2 osteosarcoma cells were a gift of T Halazonetis and were carried in Dulbecco's modi®ed Eagle media (DMEM) containing 10% fetal calf serum (Atlantic) and 100 U/ml each penicillin and streptomycin. LoVo colon carcinoma cells were obtained from the ATCC and cultured in McCoy's media containing 10% fetal calf serum and antibiotics as above. Primary baby rat kidney (BRK) cells were prepared from kidneys from 5 day old Fisher rats, cultured in DMEM including 5% fetal calf serum, and transfected as described previously (Rao et al., 1992) . To generate immortalized cell lines, BRKs were transfected with pCMV E1A plus either pCMV p53DPP and pCMVp53tsDPP and immortalized cell foci that emerged from the cell population were isolated and expanded into cell lines; two independently derived clones, designated DPP1 and DPP2, were further characterized. At the earliest passages of DPP1 and DPP2, we noted a correlation between lower plating eciencies and a slight decrease in viability beyond 3 days of incubation at 328C; however, as the cells became acclimated to culture within a few passages, their plating eciencies increased and cells remained viable at 328C for up to 12 days. A control cell line, An1, was generated by immortalization with E1A and the parental ts p53 V135 mutant. An1 has been described previously (Debbas and White, 1993) . Two derivatives of An1 were made for this study. An1/BCL-X L , which expresses human BCL-X L , was generated by transfection of An1 with the expression vector CMV-BCL-X L (K Elliott and GCP, unpublished), followed by clonal selection and expansion in growth media containing 400 mg/ml of G418. Expression of BCL-X L was con®rmed by Northern blotting. An1/neo, the vector control line for An1/BCL-X L , was generated by transfection of An1 with pcDNA3 (Invitrogen), followed by selection and expansion as above.
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Colony formation and cell transformation assays
For the colony formation inhibition assay, p53 null SAOS-2 osteosarcoma cells were transfected with 2 mg of neomycin resistant expression vector pCMVp53, pCMVp53DPP, or pcDNA3 vector, passaged 1 : 20 the next day, and incubated in DMEM containing 10% fetal calf serum plus 600 mg/ml G418 for *3 weeks. G418-resistant colonies were scored by methanol ®xation and Coomassie blue staining. For the REF transformation assay, secondary passage rat embryo ®broblasts were transfected with 5 mg each of adenovirus E1A (p1A/neo) and oncogenic RAS (pT22), plus 10 mg pcDNA3 vector, pCMVp53 or pCMVp53DPP, passaged 1 : 5 the next day, and maintained in DMEM containing 5% fetal calf serum and antibiotics. Transformed foci were scored 2 weeks post-transfection. Both the SAOS-2 and REF experiments were carried out in triplicate. BRK focus formation experiments were performed as described (White et al., 1991) . Brie¯y, BRKs were electroporated with 20 mg each pCMV-E1A (White et al., 1991) and pneoCMV H-RasV plus carrier DNA and 60 mg of pcDNA3, pCMV p53wt, and cells were cultured at 38.58C in DMEM containing 5% fetal calf serum for 3 weeks before transformed foci were scored.
BRK cell growth assay
Cells were plated at 38.58C at 10 6 cells per 10 cm plate and the viable cell number was determined by trypan blue exclusion 40 h later (time 0). The remaining dishes of cells were shifted to 328C and the number of viable cells was determined 1 ± 4 days later. The number of viable cells present on each day was computed as a percentage of the number present on day 0.
Cell viability, cell cycle and apoptosis assays
To monitor cell viability and cell cycle phase distribution, An1, DPP1 and DPP2 cells were seeded at 2610 4 cells/ 60 mm plate and incubated at 38.58C. Twenty-four hours later each cell line was trypsinized and the viable cell number was determined by trypan blue exclusion (Day 0). The remaining plates were fed with growth media and shifted to 328C. Viable cell numbers were determined at various times later. Cell morphology and¯ow cytometry analysis were carried out as described previously (Sakamuro et al., 1995) . In brief, cells were shifted to 328C and cultured for 1 or 3 days as indicated. Cell morphology was documented by photography at 1006 magni®cation on an Olympus microscope.
For determining apoptotic index, viable cultures of temperature-shifted BRK cells cultured on cover slips were treated with Hoescht 33342 (5 mg/ml) for 5 min, mounted with Fluoromount G (Southern Biotechnology Associates, Birmingham AL), and examined immediately for chromatin integrity by¯uorescence microscopy using the u.v. ®lter on the microscope. For the LoVo cell death assay, cells seeded on glass cover slips were cotransfected with a green uorescent protein (GFP) expression vector (GibcoBRL) and pcDNA3 vector, pCMVp53, or pCMVp53DPP. The next day, cells were washed and refed with growth media. Twenty-four hours later, viable cultures were stained with Hoescht 33342 and mounted with Fluoromount G (Southern Biotechnology Associates, Birmingham AL). Cells were examined immediately by¯uorescence spectroscopy using the FITC ®lter to identify green transfected cells and the u.v. ®lter to monitor chromatin status. The proportion of GFP-positive cells with a round morphology and condensed chromatin was determined relative to the total number of GFP-positive cells counted.
DNA binding (EMSA) assay
DNA binding activity of in vitro translated p53 was assayed as described previously . DNA binding buer consisted of 50 mM NaCl, 10 mM Tris HCl pH 8.0, 0.1 mM zinc acetate, 1 mM DTT and 5% glycerol. For the gel electrophoresis buer, 25 mM Tris HCl pH 8.2, 192 mM glycine and 1 mM EDTA was designed to minimize the intensity of background bands.
Immunoblotting and immunoprecipitation
The p53 monoclonal antibody pAb421 which recognizes murine and rat p53 was used. Monoclonal antibodies against p21WAF1, BAX and E1A were obtained from Oncogene Science, Santa Cruz Biotechnology, and Calbiochem respectively. Cell extracts for immunoblotting were prepared from cells incubated at 388C or 328C for the times indicated, and 25 mg cell protein as determined by Bradford assay was subjected to SDS ± PAGE and blotted onto nitrocellulose membranes by standard protocols. Immune complexes were visualized using the ECL chemiluminescence system (Amersham). For immunoprecipitation assay of wt p53 and p53DPP, in vitro translated 35 S-methionine labeled proteins and extracts from transiently transfected COS cells were analysed. pCMVp53-or pCMVDPP-transfected COS cells were metabolically labeled for 4 h in DMEM media lacking methionine and cysteine (GibcoBRL) with 100 mCi/ml EXPPESS labeling reagent (NEN) and cell extracts were prepared with NP-40 lysis buer containing protease inhibitors (Harlow and Lane, 1988) . Precleared lysate with Protein-G Sepharose beads was immunoprecipitated with mAb248 followed by the addition of fresh Protein-G beads for collection. Samples were washed four times with lysis buer, fractionated on a 10% SDS-PAGE gel, and¯uorographed.
Transactivation assays
Using methods previously described (Chen and Okayama, 1987) , DNAs were prepared as a calcium phosphate precipitate in a volume of 400 ml before addition to a 35 mm plate of 1610 5 SAOS-2 osteosarcoma cells, seeded the previous day and freshly fed 2 h before transfection. The following luciferase p53 reporter constructs (a gift of W el-Deiry) were used for transactivation assays: pG13Py-luc (multimerized wt p53 binding site), MG15Py-luc (multimerized mutant binding site), WWP-luc (WAF1 promoter). Transfections contained 0.3 mg of one of the reporter constructs, 1 mg of CMVp53 or CMVp53DPP, 0.2 mg of CMVbGal (to normalize for transfection eciency), and pcDNA3 vector up to 3 mg total DNA. Cells were harvested 48 h after transfection with 300 ml of Reporter Lysis Buer (Promega, Luciferase Assay System) and luciferase and bgal assays were performed as indicated by the vendor. Luciferase activity of each sample was normalized by dividing luciferase units by b-galactosidase units. All experiments were repeated at least twice.
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